Becton, Dickinson & Co. (BDX)
215.71
+1.19
(+0.55%)
USD |
NYSE |
Nov 12, 16:00
215.71
0.00 (0.00%)
Pre-Market: 20:00
Becton, Dickinson Net Income (Quarterly) : 696.00M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 696.00M |
| June 30, 2026 | 451.00M |
| March 31, 2026 | -37.00M |
| December 31, 2025 | 382.00M |
| September 30, 2025 | 493.00M |
| June 30, 2025 | 451.00M |
| March 31, 2025 | 158.00M |
| December 31, 2024 | 303.00M |
| September 30, 2024 | 421.00M |
| June 30, 2024 | 487.00M |
| March 31, 2024 | 537.00M |
| December 31, 2023 | 281.00M |
| September 30, 2023 | 154.00M |
| June 30, 2023 | 407.00M |
| March 31, 2023 | 460.00M |
| December 31, 2022 | 509.00M |
| September 30, 2022 | 287.00M |
| June 30, 2022 | 390.00M |
| March 31, 2022 | 390.00M |
| December 31, 2021 | 568.00M |
| September 30, 2021 | 154.00M |
| June 30, 2021 | 407.00M |
| March 31, 2021 | 299.00M |
| December 31, 2020 | 1.003B |
| September 30, 2020 | 128.00M |
| Date | Value |
|---|---|
| June 30, 2020 | 286.00M |
| March 31, 2020 | 183.00M |
| December 31, 2019 | 278.00M |
| September 30, 2019 | 150.00M |
| June 30, 2019 | 451.00M |
| March 31, 2019 | 20.00M |
| December 31, 2018 | 599.00M |
| September 30, 2018 | -135.00M |
| June 30, 2018 | 594.00M |
| March 31, 2018 | -12.00M |
| December 31, 2017 | -136.00M |
| September 30, 2017 | 327.00M |
| June 30, 2017 | -132.00M |
| March 31, 2017 | 344.00M |
| December 31, 2016 | 562.00M |
| September 30, 2016 | 19.00M |
| June 30, 2016 | 390.00M |
| March 31, 2016 | 338.00M |
| December 31, 2015 | 229.00M |
| September 30, 2015 | 181.00M |
| June 30, 2015 | 62.00M |
| March 31, 2015 | 216.00M |
| December 31, 2014 | 236.00M |
| September 30, 2014 | 301.00M |
| June 30, 2014 | 326.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| Boston Scientific Corp. | 580.00M |
| Globus Medical, Inc. | 141.17M |
| Stryker Corp. | 753.00M |
| Baxter International, Inc. | 298.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 5.274B |
| Total Expenses (Quarterly) | 4.578B |
| EPS Diluted (Quarterly) | 2.540 |
| Enterprise Value | 74.08B |
| Gross Profit Margin (Quarterly) | 51.06% |
| Profit Margin (Quarterly) | 13.20% |
| Earnings Yield | 1.92% |
| Operating Earnings Yield | 5.42% |
| Normalized Earnings Yield | 2.857 |